Supp Table 5 from <i>ATM</i> Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC

作者：Natalie I. Vokes, Ana Galán‐Cobo, Margarita Fernandez-Chas, David Molkentine, Santiago Treviño, Vitaly Druker, Yu Qian, Sonia Patel, Stephanie Schmidt, Lingzhi Hong, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, J. Jack Lee, Marcelo V. Negrão, Don L. Gibbons, Ara A. Vaporciyan, Xiuning Le, Jia Wu, Jianjun Zhang, Una Rigney, Sonia Iyer, Emma Dean, John V. Heymach · 年份：2025 · DOI：10.1158/1078-0432.30902819 · 研究领域：Lung Cancer Treatments and Mutations、Cancer Genomics and Diagnostics、Lung Cancer Research Studies

<p>Supp Table 5. Flatiron Health-Foundation Medicine Clinicogenomic Database (FH-FMI CGDB) cohort characteristics, overall and stratified by treatment with chemotherapy along (Chemo), immune checkpoint inhibitor monotherapy (ICI), or combination ICI with chemotherapy (ICI-chemo)</p>